Search

Your search keyword '"Kosaka, Shinji"' showing total 2 results
Start Over Author "Kosaka, Shinji" Topic magnetic resonance imaging
2 results on '"Kosaka, Shinji"'

1. Minimally invasive diagnosis and treatment of traumatic rupture of the right hemidiaphragm with liver herniation.

Author

Sato M and Kosaka S

Subjects
Diaphragm surgery, Emergencies, Hernia diagnosis, Hernia etiology, Herniorrhaphy, Humans, Liver Diseases etiology, Liver Diseases surgery, Male, Middle Aged, Rupture, Thoracoscopy, Diaphragm injuries, Diaphragm pathology, Liver Diseases diagnosis, Magnetic Resonance Imaging
Abstract

We report a case of blunt traumatic rupture of the right hemidiaphragm with liver herniation. A 57-year-old man admitted in an emergency after a traffic accident was suspected from chest radiography and computed tomography to have traumatic diaphragmatic rupture. Magnetic resonance imaging was helpful in the final diagnosis. Thoracoscopy was useful in planning surgery and surgically repairing the ruptured diaphragm.

Published
2002
Full Text
View/download PDF

2. Uterine sarcoma with posterior reversible encephalopathy syndrome associated with pazopanib.

Author

Tatsumichi, Takakiyo, Tanaka, Hiroaki, Okazaki, Tomoya, Takahashi, Koichi, Suzuki, Kiyo, Kawakita, Kenya, Houchi, Hitoshi, Kuroda, Yasuhiro, and Kosaka, Shinji

Subjects
ANTINEOPLASTIC agents, BRAIN, SEIZURES (Medicine), DRUG side effects, MAGNETIC resonance imaging, SARCOMA, UTERINE tumors, PROTEIN-tyrosine kinase inhibitors, TREATMENT effectiveness, POSTERIOR leukoencephalopathy syndrome
Abstract

What is known and objective: Our objective is to report on a case of posterior reversible encephalopathy syndrome associated with pazopanib. Case description: A 64‐year‐old patient with uterine sarcoma developed PRES 3 days after pazopanib was initiated. After the discontinuation of pazopanib, the symptoms of PRES improved. What is new and Conclusion: The first report worldwide to describe a patient with uterine sarcoma experiencing PRES caused by pazopanib. Patients with uterine sarcoma may experience PRES, even in the early phase of pazopanib therapy. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results